Literature DB >> 8794020

Cytotoxic T lymphocyte responses to Epstein-Barr virus.

A B Rickinson1, S P Lee, N M Steven.   

Abstract

Epstein-Barr virus induces a potent cytotoxic T lymphocyte response in man that is preferentially directed towards a particular subset of the virus latent cycle antigens; the immunodominance of these proteins, apparent in both primary and memory responses, may reflect some differential access to the HLA class I processing pathway. Effector cells recognizing these immunodominant antigens can reverse the growth of virus-induced lymphoproliferative lesions in immunosuppressed patients; however, responses to some of the subdominant latent proteins will be needed to target other virus-positive tumours.

Entities:  

Mesh:

Year:  1996        PMID: 8794020     DOI: 10.1016/s0952-7915(96)80036-7

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  15 in total

1.  Functional analysis of the CD4(+) T-cell response to Epstein-Barr virus: T-cell-mediated activation of resting B cells and induction of viral BZLF1 expression.

Authors:  Z Fu; M J Cannon
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Type 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.

Authors:  P Steigerwald-Mullen; M G Kurilla; T J Braciale
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 3.  Memory CD8 T-cell differentiation during viral infection.

Authors:  E John Wherry; Rafi Ahmed
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

Review 4.  Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts.

Authors:  R J O'Reilly; T N Small; E Papadopoulos; K Lucas; J Lacerda; L Koulova
Journal:  Springer Semin Immunopathol       Date:  1998

Review 5.  The complexity of the Epstein-Barr virus infection in humans.

Authors:  E Klein
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

6.  Current knowledge of MicroRNAs and noncoding RNAs in virus-infected cells.

Authors:  Dominique L Ouellet; Patrick Provost
Journal:  Methods Mol Biol       Date:  2010

7.  Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes.

Authors:  Stéphane Vigouroux; Eric Yvon; Hans-Joachim Wagner; Ettore Biagi; Gianpietro Dotti; Uluhan Sili; Cecilia Lira; Cliona M Rooney; Malcolm K Brenner
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 8.  Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD.

Authors:  G Tosato; J Teruya-Feldstein; J Setsuda; S E Pike; K D Jones; E S Jaffe
Journal:  Springer Semin Immunopathol       Date:  1998

Review 9.  Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD).

Authors:  M A Nalesnik
Journal:  Springer Semin Immunopathol       Date:  1998

10.  Interleukin-18, interferon-gamma, IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative disease.

Authors:  J Setsuda; J Teruya-Feldstein; N L Harris; J A Ferry; L Sorbara; G Gupta; E S Jaffe; G Tosato
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.